Clinical Trial Update: Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

View source ↗

Summary

This clinical trial update notes recruitment for a study evaluating durvalumab as consolidation therapy after definitive chemoradiation in patients with limited…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: SCLC, Limited Stage | Status: RECRUITING